Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 (TREATNOW)

Clinical Trial ID NCT04372628

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04372628

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020 10.90
2 Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 9.53
3 A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020 9.42
4 A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020 7.78
5 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 6.59
6 Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother 2014 1.34
7 Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 2004 1.30
8 Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A 2004 1.25
9 Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004 1.20
10 Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect 2013 1.19
11 In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004 1.05
12 Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep 2016 0.98
13 Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 2016 0.96
14 Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis 2015 0.92
15 Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. Int J Antimicrob Agents 2014 0.88
16 Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome. Antivir Ther 2015 0.76
17 Another Decade, Another Coronavirus. N Engl J Med 2020 0.75
18 Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect 2017 0.75
Next 100